Exacerbating factors and disease burden in patients with atopic dermatitis

…, H Morisaki, M Matsumoto, M Takenaka - Allergology …, 2022 - jstage.jst.go.jp
The number of patients with atopic dermatitis is on the rise worldwide, and Japan is no
exception. According to recent estimates of the percentage of patients with atopic dermatitis in …

CD19 regulates skin and lung fibrosis via Toll-like receptor signaling in a model of bleomycin-induced scleroderma

…, F Ogawa, T Hara, E Muroi, M Takenaka… - The American journal of …, 2008 - Elsevier
Mice subcutaneously injected with bleomycin, in an experimental model of human systemic
sclerosis, develop cutaneous and lung fibrosis with autoantibody production. CD19 is a …

Cell adhesion molecules regulate fibrotic process via Th1/Th2/Th17 cell balance in a bleomycin-induced scleroderma model

…, E Muroi, T Hara, F Ogawa, M Takenaka… - The Journal of …, 2010 - journals.aai.org
Mice sc injected with bleomycin, an experimental model for human systemic sclerosis, develop
skin and lung fibrosis, which is mediated by inflammatory cell infiltration. This process is …

Correlation of IgE autoantibody to BP180 with a severe form of bullous pemphigoid

…, T Hara, E Muroi, F Ogawa, M Takenaka… - Archives of …, 2008 - jamanetwork.com
Objective To determine the prevalence, immunoglobulin subclass distribution, and clinical
correlation of antibodies (Abs), especially of IgE Abs, to BP180 and BP230 in patients with …

Treatment with rapamycin prevents fibrosis in tight‐skin and bleomycin‐induced mouse models of systemic sclerosis

…, Y Iwata, K Komura, F Ogawa, M Takenaka… - Arthritis & …, 2010 - Wiley Online Library
Objective Rapamycin, a novel macrolide immunosuppressive drug, is increasingly used as
an agent for posttransplant immunosuppression and treatment of autoimmune disease. The …

Clinical significance of serum HMGB-1 and sRAGE levels in systemic sclerosis: association with disease severity

…, F Ogawa, T Hara, E Muroi, M Takenaka… - Journal of clinical …, 2009 - Springer
Introduction The high mobility group box 1 protein (HMGB-1)/advanced glycation end
products (RAGE) system is recently shown to play an important part in immune/inflammatory …

CD19, a response regulator of B lymphocytes, regulates wound healing through hyaluronan-induced TLR4 signaling

…, F Ogawa, T Hara, E Muroi, S Bae, M Takenaka… - The American journal of …, 2009 - Elsevier
Immune cells are critical to the wound-healing process, through both cytokine and growth
factor secretion. Although previous studies have revealed that B cells are present within …

[HTML][HTML] The loss of MCP-1 attenuates cutaneous ischemia–reperfusion injury in a mouse model of pressure ulcer

…, T Matsushita, M Horikawa, M Takenaka… - Journal of Investigative …, 2008 - Elsevier
The formation of pressure ulcers is dependent on multiple factors including ischemia–reperfusion
(IR). This study assessed the mechanism of a previously reported murine model of …

Prognosis of patients with adult T‐cell leukemia/lymphoma in Japan: a nationwide hospital‐based study

…, M Fukazawa, M Shindo, M Takenaka… - Cancer …, 2020 - Wiley Online Library
Adult T‐cell leukemia/lymphoma (ATL) is a mature T‐cell neoplasm and is classified into
four subtypes (acute, lymphoma, chronic, and smoldering) according to the Shimoyama …

[HTML][HTML] Platelets control leukocyte recruitment in a murine model of cutaneous arthus reaction

…, K Yanaba, Y Iwata, E Muroi, M Takenaka… - The American journal of …, 2010 - Elsevier
Platelets have been shown to be important in inflammation, but their role in the cutaneous
Arthus reaction remains unclear. To assess the role of platelets in this pathogenetic process, …